Overview

Eylea 40mg/ml Injection contains the active constituent Aflibercept. It is used to treat eye conditions in which impaired vision occurs due to the formation of an abnormal blood vessel inside the eye. These include wet age-related macular degeneration and diabetic macular edema. In studies, this medication effectively reduces the risk of vision loss and improves visual acuity in people with these conditions. Most patients generally well-tolerated it, and the injection procedure is relatively quick and minimally invasive.